Literature DB >> 16920146

Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?

Jørgen K Kanters1, Claus Graff, Mads P Andersen, Thomas Hardahl, Egon Toft, Michael Christiansen, Poul Erik Bloch Thomsen, Johannes J Struijk.   

Abstract

Diagnosis of long QT syndrome (LQTS) is difficult. A prolonged QT interval is easily overlooked, and in 10% of all patients with LQTS, the QT interval is normal. Genotyping is unfortunately not able to detect all patients and healthy subjects correctly. Although QT prolongation is the most used risk parameter, there is no clear correlation between the prolonged QT interval and the risk of arrhythmias in drug-induced LQTS. Quantification of T-wave morphology is a promising method that is able to provide more information about repolarization than QT prolongation alone. It is a fact that ECG evaluation can serve as a guide for genotyping and can reduce the costs by suggesting which gene to start sequencing, but it is fiction that the ECG can replace genotyping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920146     DOI: 10.1016/j.jelectrocard.2006.06.008

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  3 in total

Review 1.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

2.  Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.

Authors:  Claus Graff; Johannes J Struijk; Jørgen K Kanters; Mads P Andersen; Egon Toft; Benoît Tyl
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

3.  Assessment of ventricular repolarization variability with the DeltaT50 method improves identification of patients with congenital long QT syndromes.

Authors:  Christina Abrahamsson; Corina Dota; Bo Skallefell; Leif Carlsson; Lars Frison; Anders Berggren; Nils Edvardsson; Göran Duker
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.